“…Whereas little is known about the experience of isolation in BCUs (both immunocompromised patients, placed in protective or reverse isolation, and patients with infectious diseases, placed in source isolation), studies of other medical isolation settings have examined the demands and stressors on isolated patients (Catalano et al, 2003;Collins et al, 1989;Gammon, 1998;Gaskill et al, 1997;Jones, 2010;Knowles, 1993;Linda Barratt et al, 2011;Parkinson, 2006;Purssell et al, 2020;Rees et al, 2000;Shaban et al, 2020;Vottero & Rittenmeyer, 2012). The outbreak of COVID-19 has led to increased interest in the negative consequences of (prolonged) isolation of highly infectious patients (Hossain et al, 2020;Shaban et al, 2020).…”